SCHEMBL4855770

SCHEMBL4855770

CCC1(CC)CCC(c2ccccc2N2CCN(C(=O)N3CCCCC3)CC2)CC1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.48
LMNA P02545 2/20 0.48
MEN1 O00255 2/20 0.48
ALDH1A1 P00352 6/20 0.42
HTR1A P08908 1/20 0.42
ADRA1B P35368 1/20 0.42
TSHR P16473 2/20 0.41
AKR1C3 P42330 4/20 0.41
GAA P10253 2/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
NPSR1 Q6W5P4 3/20 0.40
MAPT P10636 3/20 0.40
HPGD P15428 2/20 0.40
KDM4E B2RXH2 1/20 0.40
USP2 O75604 1/20 0.39
HTT P42858 1/20 0.38
P2RX1 P51575 1/20 0.38
P2RX3 P56373 1/20 0.38
P2RX4 Q99571 1/20 0.38
GFER P55789 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4857745 0.89 AKR1C3 (0.56) ALDH1A1TSHRAKR1C3HPGDKDM4E
SCHEMBL27671027 0.87 HTR1A (0.42) KMT2ALMNAMEN1ALDH1A1HTR1A
SCHEMBL4853943 0.84 MAPT (0.44) KMT2ALMNAMEN1ALDH1A1TSHR
SCHEMBL4251027 0.82 GPR119 (0.46) KMT2ALMNAMEN1GAASMN1; SMN2
Hydrochloric Acid SCHEMBL4855946 0.79 HTR1A (0.43) KMT2ALMNAMEN1ALDH1A1HTR1A
SCHEMBL4857386 0.77 HTR1A (0.49) LMNAHTR1ATSHRMAPT
Hydrochloric Acid SCHEMBL4859541 0.76 HTR1A (0.50) LMNAHTR1AADRA1BKDM4E
SCHEMBL27752291 0.76 HTR1A (0.45) HTR1AADRA1B
SCHEMBL4855777 0.75 HTR1A (0.39) HTR1AADRA1B
Hydrochloric Acid SCHEMBL4850877 0.75 HTR1A (0.44) HTR1AADRA1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1698620-B1 BENZENE COMPOUNDS DISUBSTITUTED WITH CYCLIC GROUPS AT THE 1- AND 2-POSITIONS EISAI R&D MAN CO LTD (JP) 2016-09-28 EP disclosed
US-7425554-B2 1,2-di(cyclic)substituted benzene compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2008-09-16 US disclosed
US-7410971-B2 1,2-di(cyclic)substituted benzene compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2008-08-12 US disclosed
US-20070112002-A1 1,2-di(cyclic)substituted benzene compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2007-05-17 US disclosed
US-20060276465-A1 1,2-di(cyclic) substituted benzene compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2006-12-07 US disclosed
EP-1698620-A1 BENZENE COMPOUNDS DISUBSTITUTED WITH CYCLIC GROUPS AT THE 1- AND 2-POSITIONS Eisai Co., Ltd. (JP) 2006-09-06 EP disclosed
US-20050261291-A1 1,2-Di(cyclic)substituted benzene compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2005-11-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070112002-A1 1,2-di(cyclic)substituted benzene compounds CCR10, HRH3, HRH1 KMT2A 3129/4885LMNA 4851/4885MEN1 3432/4885
US-20050261291-A1 1,2-Di(cyclic)substituted benzene compounds CCR10, HRH3, HRH2 KMT2A 2951/4885LMNA 4842/4885MEN1 2969/4885
US-20060276465-A1 1,2-di(cyclic) substituted benzene compounds HRH3, CCR10, HRH1 KMT2A 3396/4885LMNA 4801/4885MEN1 2159/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.